Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 90

1.

Meta- and pooled analyses of the cytochrome P-450 1B1 Val432Leu polymorphism and breast cancer: a HuGE-GSEC review.

Paracchini V, Raimondi S, Gram IT, Kang D, Kocabas NA, Kristensen VN, Li D, Parl FF, Rylander-Rudqvist T, Soucek P, Zheng W, Wedren S, Taioli E.

Am J Epidemiol. 2007 Jan 15;165(2):115-25. Epub 2006 Oct 19. Review.

PMID:
17053044
2.

No association between CYP1B1 Val432Leu polymorphism and breast cancer risk: a meta-analysis involving 40,303 subjects.

Yao L, Fang F, Wu Q, Zhong Y, Yu L.

Breast Cancer Res Treat. 2010 Jul;122(1):237-42. doi: 10.1007/s10549-009-0689-2. Epub 2009 Dec 24.

PMID:
20033481
3.

Catechol-O-methyltransferase and cytochrome P-450 1B1 polymorphisms and endometrial cancer risk: a meta-analysis.

Teng Y, He C, Zuo X, Li X.

Int J Gynecol Cancer. 2013 Mar;23(3):422-30. doi: 10.1097/IGC.0b013e3182849e0d.

PMID:
23370603
4.

Association of the CYP1B1 Leu432Val polymorphism with the risk of prostate cancer: a meta-analysis.

Cui L, Dillehay K, Chen W, Shen D, Dong Z, Li W.

Mol Biol Rep. 2012 Jul;39(7):7465-71. doi: 10.1007/s11033-012-1579-y. Epub 2012 Feb 11.

PMID:
22327650
5.

Soy isoflavones, CYP1A1, CYP1B1, and COMT polymorphisms, and breast cancer: a case-control study in southwestern China.

Wang Q, Li H, Tao P, Wang YP, Yuan P, Yang CX, Li JY, Yang F, Lee H, Huang Y.

DNA Cell Biol. 2011 Aug;30(8):585-95. doi: 10.1089/dna.2010.1195. Epub 2011 Mar 27.

PMID:
21438753
6.

Association of cytochrome P450 1B1 (CYP1B1) polymorphism with steroid receptor status in breast cancer.

Bailey LR, Roodi N, Dupont WD, Parl FF.

Cancer Res. 1998 Nov 15;58(22):5038-41. Erratum in: Cancer Res 1999 Mar 15;59(6):1388.

7.

Three polymorphisms in cytochrome P450 1B1 (CYP1B1) gene and breast cancer risk: a meta-analysis.

Economopoulos KP, Sergentanis TN.

Breast Cancer Res Treat. 2010 Jul;122(2):545-51. doi: 10.1007/s10549-009-0728-z. Epub 2010 Jan 7. Review.

PMID:
20054638
8.

Association of single nucleotide polymorphisms in CYP1B1 and COMT genes with breast cancer susceptibility in Indian women.

Yadav S, Singhal NK, Singh V, Rastogi N, Srivastava PK, Singh MP.

Dis Markers. 2009;27(5):203-10. doi: 10.3233/DMA-2009-0663.

9.
10.

Interaction between genetic polymorphism of cytochrome P450-1B1 and environmental pollutants in breast cancer risk.

Saintot M, Malaveille C, Hautefeuille A, Gerber M.

Eur J Cancer Prev. 2004 Feb;13(1):83-6.

PMID:
15075793
11.

Meta-analysis and pooled analysis of GSTM1 and CYP1A1 polymorphisms and oral and pharyngeal cancers: a HuGE-GSEC review.

Varela-Lema L, Taioli E, Ruano-Ravina A, Barros-Dios JM, Anantharaman D, Benhamou S, Boccia S, Bhisey RA, Cadoni G, Capoluongo E, Chen CJ, Foulkes W, Goloni-Bertollo EM, Hatagima A, Hayes RB, Katoh T, Koifman S, Lazarus P, Manni JJ, Mahimkar M, Morita S, Park J, Park KK, Pavarino Bertelli EC, de Souza Fonseca Ribeiro EM, Roy B, Spitz MR, Strange RC, Wei Q, Ragin CC.

Genet Med. 2008 Jun;10(6):369-84. doi: 10.1097/GIM.0b013e3181770196.

12.

CYP1B1 and CYP19 gene polymorphisms and breast cancer incidence: no association in the ARIC study.

Thyagarajan B, Brott M, Mink P, Folsom AR, Anderson KE, Oetting WS, Gross M.

Cancer Lett. 2004 Apr 30;207(2):183-9.

PMID:
15072827
13.

The CYP1B1 Leu432Val polymorphism contributes to lung cancer risk: evidence from 6501 subjects.

Chen B, Qiu LX, Li Y, Xu W, Wang XL, Zhao WH, Wu JQ.

Lung Cancer. 2010 Dec;70(3):247-52. doi: 10.1016/j.lungcan.2010.03.011. Epub 2010 Apr 14.

PMID:
20395011
14.

CYP1A1 and CYP1B1 polymorphisms and risk of lung cancer among never smokers: a population-based study.

Wenzlaff AS, Cote ML, Bock CH, Land SJ, Santer SK, Schwartz DR, Schwartz AG.

Carcinogenesis. 2005 Dec;26(12):2207-12. Epub 2005 Jul 28.

PMID:
16051642
15.

Case-control study of ovarian cancer and polymorphisms in genes involved in catecholestrogen formation and metabolism.

Goodman MT, McDuffie K, Kolonel LN, Terada K, Donlon TA, Wilkens LR, Guo C, Le Marchand L.

Cancer Epidemiol Biomarkers Prev. 2001 Mar;10(3):209-16.

16.

Association of CYP1B1 polymorphisms and breast cancer risk.

De Vivo I, Hankinson SE, Li L, Colditz GA, Hunter DJ.

Cancer Epidemiol Biomarkers Prev. 2002 May;11(5):489-92.

17.

Genetic polymorphisms of cytochrome P450 19 and 1B1, alcohol use, and breast cancer risk in Korean women.

Lee KM, Abel J, Ko Y, Harth V, Park WY, Seo JS, Yoo KY, Choi JY, Shin A, Ahn SH, Noh DY, Hirvonen A, Kang D.

Br J Cancer. 2003 Mar 10;88(5):675-8.

18.

[Polymorphisms of CYP1B1 and COMT in breast and endometrial cancer].

Zimarina TC, Kristensen VN, Imianitov EN, Bershteń≠n LM.

Mol Biol (Mosk). 2004 May-Jun;38(3):386-93. Russian.

PMID:
15285606
19.

Cytochrome P450 1B1 gene polymorphisms and postmenopausal breast cancer risk.

Rylander-Rudqvist T, Wedren S, Granath F, Humphreys K, Ahlberg S, Weiderpass E, Oscarson M, Ingelman-Sundberg M, Persson I.

Carcinogenesis. 2003 Sep;24(9):1533-9. Epub 2003 Jul 4.

PMID:
12844487
20.

Association of CYP1B1 Leu432Val polymorphism and lung cancer risk: an updated meta-analysis.

Lao X, Qin X, Peng Q, Chen Z, Lu Y, Liu Y, Li S.

Lung. 2014 Oct;192(5):739-48. doi: 10.1007/s00408-014-9618-1. Epub 2014 Jul 3. Review.

PMID:
24989113

Supplemental Content

Support Center